Measuring Genes in Pancreatic Juice for Cancer Diagnosis
Author Information
Author(s): Oliveira-Cunha M, Byers R J, Siriwardena A K
Primary Institution: Manchester Royal Infirmary
Hypothesis
Detection of gene signatures in pancreatic ductal juice will correlate with those in tumor samples from the same patients.
Conclusion
RNA analysis of pancreatic juice is feasible and can distinguish between benign and malignant pancreatic tissue.
Supporting Evidence
- One gene, ANXA1, showed a significant correlation of expression level between pancreatic juice and tissue samples.
- Three genes, IGFBP3, PSCA, and SPINK1, showed significantly different expression between cancerous and benign pancreatic tissue samples.
- The study included 41 patients with pancreatic juice samples and matched tissue samples.
Takeaway
Doctors can check for cancer by looking at tiny bits of juice from the pancreas instead of needing a big piece of tissue.
Methodology
RNA was extracted from pancreatic juice and tissue samples, followed by poly(A) PCR and real-time PCR to measure gene expression levels.
Limitations
RNA quality may limit the application of the technique, and the origin of mRNAs in pancreatic juice is unclear.
Participant Demographics
Patients undergoing pancreaticoduodenectomy for suspected tumor, including those with pancreatic cancer and chronic pancreatitis.
Statistical Information
P-Value
P⩽0.001 for PSCA
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website